Specializing in biopreservation tools for cell and gene therapies, this company provides critical storage and shipping solutions for the life sciences industry. Investors monitor BioLife Solutions for its exposure to the growing regenerative medicine market and its partnerships with biopharma firms.
2 members of Congress have disclosed 6 trades in BioLife Solutions, Inc. (BLFS), a Healthcare company. The buy/sell breakdown shows 5 purchases versus 1 sale, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2022-12-12 | Christopher L. Jacobs | sell | $1K – $15K |
| 2022-11-08 | Christopher L. Jacobs | buy | $1K – $15K |
| 2020-07-07 | Tom Malinowski | buy | $1K – $15K |
| 2020-06-19 | Tom Malinowski | buy | $1K – $15K |
| 2020-06-17 | Tom Malinowski | buy | $15 – $50 |
| 2020-06-17 | Tom Malinowski | buy | $15K – $50K |